Citadel Advisors’s Viemed Healthcare VMD Stock Holding History

Citadel Advisors’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-300	Closed	-$2.18K	–	15285
2025 Q1	$2.18K	Sell	300 -1,900	-86%	-$14.9K	﹤0.01%	14058
2024 Q4	$17.6K	Sell	2,200 -200	-8%	-$1.74K	﹤0.01%	13249
2024 Q3	$17.6K	Buy	2,400 +1,400	+140%	+$10K	﹤0.01%	12877
2024 Q2	$6.55K	Sell	1,000 -2,300	-70%	-$17.3K	﹤0.01%	13322
2024 Q1	$31.1K	Buy	3,300 +1,800	+120%	+$15.4K	﹤0.01%	12667
2023 Q4	$11.8K	Buy	1,500 +800	+114%	+$5.8K	﹤0.01%	13025
2023 Q3	$4.71K	Sell	700 -8,300	-92%	-$68K	﹤0.01%	13460
2023 Q2	$88K	Sell	9,000 -2,800	-24%	-$28.4K	﹤0.01%	11119
2023 Q1	$114K	Buy	11,800 +5,900	+100%	+$51.4K	﹤0.01%	11073
2022 Q4	$44.6K	Buy	+5,900	New	+$40K	﹤0.01%	12270

Other funds holding VMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Citadel Advisors's VMD Position: Q1 2026 in Review

Citadel Advisors reduced its Viemed Healthcare (VMD) stake by 81% in Q1 2026, selling an estimated $406K and leaving 11,730 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #11941.

Citadel Advisors first reported a position in VMD in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.01M in Q2 2022. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

Citadel Advisors held 11,730 shares of Viemed Healthcare worth $108K as of Q1 2026.
Citadel Advisors sold 48,753 Viemed Healthcare shares in Q1 2026, an estimated $406K.
Viemed Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11941 holding.
Citadel Advisors first reported a position in Viemed Healthcare in Q3 2020 and has held it in 23 quarters since.
Citadel Advisors's Viemed Healthcare position peaked at $1.01M in Q2 2022.
149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.